Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7

Caro, 2012, Modeling good research practices - overview: A report of the ISPOR-SMDM modeling good research practices task force-1, Value Health, 15, 796, 10.1016/j.jval.2012.06.012

Roberts, 2012, Conceptualizing a model: A report of the ISPOR-SMDM modeling good research practices task force-2, Value Health, 15, 804, 10.1016/j.jval.2012.06.016

Siebert, 2012, State-transition modeling: A report of the ISPOR-SMDM modeling good research practices task force-3, Value Health, 15, 812, 10.1016/j.jval.2012.06.014

Karnon, 2012, Modeling using discrete event simulation: A report of the ISPOR-SMDM modeling good research practices task force-4, Value Health, 15, 821, 10.1016/j.jval.2012.04.013

Pitman, 2012, Dynamic transmission modeling: A report of the ISPOR-SMDM modeling good research practices task force-5, Value Health, 15, 828, 10.1016/j.jval.2012.06.011

Briggs, 2012, Model parameter estimation and uncertainty: A report of the ISPOR-SMDM modeling good research practices task force-6, Value Health, 15, 835, 10.1016/j.jval.2012.04.014

Goeree, 2004, Principles of good modeling practice in healthcare cost-effectiveness studies, Expert Rev Pharmacoecon Outcomes Res, 4, 189, 10.1586/14737167.4.2.189

Karnon, 2007, A review and critique of modelling in prioritising and designing screening programmes, Health Technol Assess, 11, 10.3310/hta11520

Kopec, 2010, Validation of population-based disease simulation models: a review of concepts and methods, BMC Public Health, 10, 710, 10.1186/1471-2458-10-710

Philips, 2006, Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment, Pharmacoeconomics, 24, 355, 10.2165/00019053-200624040-00006

Philips, 2004, Review of guidelines for good practice in decision-analytic modelling in health technology assessment, Health Technol Assess (Winchester, England), 8, iii

Sculpher, 2000, Assessing quality in decision analytic cost-effectiveness models: a suggested framework and example of application, Pharmacoeconomics, 17, 461, 10.2165/00019053-200017050-00005

Weinstein, 2003, Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies, Value Health, 6, 9, 10.1046/j.1524-4733.2003.00234.x

Weinstein, 2001, Modeling for health care and other policy decisions: uses, roles, and validity, Value Health, 4, 348, 10.1046/j.1524-4733.2001.45061.x

Weinstein, 1987, Forecasting coronary heart disease incidence, mortality, and cost: the coronary heart disease policy model, Am J Pub Health, 77, 1417, 10.2105/AJPH.77.11.1417

Owens, 2002, Analytic tools for public health decision making, Med Decis Making, 22, S3, 10.1177/027298902237969

Freedberg, 2001, The cost effectiveness of combination antiretroviral therapy for HIV disease, N Engl J Med, 344, 824, 10.1056/NEJM200103153441108

Goldie, 2006, Cost-effectiveness of HIV treatment in resource-poor settings--the case of Cote d'Ivoire, N Engl J Med, 355, 1141, 10.1056/NEJMsa060247

Paltiel, 2005, Expanded screening for HIV in the United States–an analysis of cost-effectiveness, N Engl J Med, 352, 586, 10.1056/NEJMsa042088

Walensky, 2009, When to start antiretroviral therapy in resource-limited settings, Ann Int Med, 151, 157, 10.7326/0003-4819-151-3-200908040-00138

Weinstein, 2001, Use of genotypic resistance testing to guide HIV therapy: clinical impact and cost-effectiveness, Ann Int Med, 134, 440, 10.7326/0003-4819-134-6-200103200-00008

Owens, 1995, Screening surgeons for HIV infection: a cost-effectiveness analysis, Ann Int Med, 122, 641, 10.7326/0003-4819-122-9-199505010-00001

Sanders, 2005, Cost-effectiveness of implantable cardioverter-defibrillators, N Engl J Med, 353, 1471, 10.1056/NEJMsa051989

Schlessinger, 2002, Archimedes: a new model for simulating health care systems–the mathematical formulation, J Biomed Inform, 35, 37, 10.1016/S1532-0464(02)00006-0

Eddy, 2003, Validation of the Archimedes diabetes model, Diabetes Care, 26, 3102, 10.2337/diacare.26.11.3102

Stern, 2008, Validation of prediction of diabetes by the Archimedes model and comparison with other predicting models, Diab Care, 31, 1670, 10.2337/dc08-0521

Kahn, 2010, Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis, Lancet, 375, 1365, 10.1016/S0140-6736(09)62162-0

Laine, 2007, Reproducible research: moving toward research the public can really trust, Ann Intern Med, 146, 450, 10.7326/0003-4819-146-6-200703200-00154

Morin, 2012, Research priorities: shining light into black boxes, Science, 336, 159, 10.1126/science.1218263

Peng, 2009, Reproducible research and biostatistics, Biostatistics, 10, 405, 10.1093/biostatistics/kxp014

Peng, 2011, Reproducible research in computational science, Science, 334, 1226, 10.1126/science.1213847

Peng, 2006, Reproducible epidemiologic research, Am J Epidemiol, 163, 783, 10.1093/aje/kwj093

2012

DeAngelis, 2010, The importance of independent academic statistical analysis, Biostatistics, 11, 383, 10.1093/biostatistics/kxq027

Drummond, 1993, Standardizing methodologies for economic evaluation in health care: practice, problems, and potential, Int J Technol Assess Health Care, 9, 26, 10.1017/S0266462300003007

Groves, 2010, The wider concept of data sharing: view from the BMJ, Biostatistics, 11, 391, 10.1093/biostatistics/kxq031

Baggerly, 2010, Disclose all data in publications, Nature, 467, 401, 10.1038/467401b

Keiding, 2010, Reproducible research and the substantive context, Biostatistics, 11, 376, 10.1093/biostatistics/kxq033

McHaney, 1991

Barter, 2007, Effects of torcetrapib in patients at high risk for coronary events, N Eng J Med, 357, 2109, 10.1056/NEJMoa0706628

Bratley, 1987

Law, 2007

Thesen, 1992

Drummond, 2005, Analytic choices in economic models of treatments for rheumatoid arthritis: what makes a difference?, Med Decis Making, 25, 520, 10.1177/0272989X05280561

Berry, 2005, Effect of screening and adjuvant therapy on mortality from breast cancer, N Engl J Med, 353, 1784, 10.1056/NEJMoa050518

2007, Computer modeling of diabetes and its complications: a report on the Fourth Mount Hood Challenge Meeting, Diabetes Care, 30, 1638, 10.2337/dc07-9919

Zauber, 2008, Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force, Ann Int Med, 149, 659, 10.7326/0003-4819-149-9-200811040-00244

Stout, 2009, Calibration methods used in cancer simulation models and suggested reporting guidelines, Pharmacoeconomics, 27, 533, 10.2165/11314830-000000000-00000

Royle, 2003, Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system, Health Technol Assess, 7, 1, 10.3310/hta7340

Haynes, 2005, Optimal search strategies for retrieving scientifically strong studies of treatment from Medline: analytical survey, BMJ, 330, 1179, 10.1136/bmj.38446.498542.8F

Haynes, 2004, Optimal search strategies for retrieving scientifically strong studies of diagnosis from Medline: analytical survey, BMJ, 328, 1040, 10.1136/bmj.38068.557998.EE

Montori, 2005, Optimal search strategies for retrieving systematic reviews from Medline: analytical survey, BMJ, 330, 68, 10.1136/bmj.38336.804167.47

Goldhaber-Fiebert, 2010, Empirically evaluating decision-analytic models, Value Health, 13, 667, 10.1111/j.1524-4733.2010.00698.x

Eddy, 1987, The frequency of cervical cancer screening: comparison of a mathematical model with empirical data, Cancer, 60, 1117, 10.1002/1097-0142(19870901)60:5<1117::AID-CNCR2820600533>3.0.CO;2-H